Sight Sciences Inc is a medical technology company focused on developing innovative solutions for the treatment of eye diseases, particularly those related to glaucoma and dry eye
The company's flagship products aim to enhance patient outcomes through minimally invasive procedures, utilizing advanced technologies to improve surgical techniques and patient safety. As a leader in ocular health, Sight Sciences is dedicated to advancing the standard of care in ophthalmology by providing healthcare professionals with effective tools and resources to address the challenges faced by patients with chronic eye conditions.
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.
Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology. FLJ Group shares jumped 96.4% to $0.2123 on Friday.
